Condition: Myeloproliferative Neoplasm · Sponsor: University Hospital, Bordeaux
Myeloproliferative Neoplasms (MPN) are associated with an increased risk of thrombosis. Platelets, red blood cells (RBC), leukocytes and endothelial cells are involved in these complications. An association with the JAK2V617F allele burden assessed in leukocytes has also been suggested. In some patients the allele burden measured in platelets and red blood cells is higher than the one determined in leukocytes. Our project aims at associating the risk of thrombosis with the allele burden determined in the cell populations (platelets, red blood cells, granulocytes and endothelial cells) and identifying high-risk clonality profiles.
This description comes directly from the study's public registry record.
Olivier MANSIER · 05 56 79 56 79 · olivier.mansier@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU d'Angers, Service Maladies du Sang | Angers, France | Recruiting |
| CH de Bayonne, Service Hématologie Clinique | Bayonne, France | Recruiting |
| CHU de Bordeaux, Service Médecine Interne et Maladies Infectieuses | Bordeaux, France | Recruiting |
| Institut Bergonié, Service Hématologie Clinique | Bordeaux, France | Recruiting |
| CHU de Brest, Service Hématologie Clinique | Brest, France | Recruiting |
| CH de Dax, Service Hématologie Clinique | Dax, France | Recruiting |
| CH de Libourne, Service Hématologie Clinique | Libourne, France | Recruiting |
| CH de Mont de Marsan, Service Oncologie | Mont-de-Marsan, France | Recruiting |
| CHU de Bordeaux, Service Hématologie Biologie | Pessac, France | Recruiting |
| CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire | Pessac, France | Recruiting |
| CHU de Bordeaux, Service Médecine Interne | Pessac, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05839717